Coordinación de Investigación en Salud, Mexico
Quick facts
Marketed products
- starch tablets · Nutritional supplement / Pharmaceutical excipient
Starch tablets provide a source of carbohydrates for nutritional supplementation or as a pharmaceutical excipient/filler. - Telmisartan plus Captopril
- Triticum Aestivum · Nutritional Support / Immunomodulation
Triticum aestivum (wheat) extract provides nutritional and immunomodulatory support through its polysaccharide and micronutrient content.
Phase 3 pipeline
- Collagen-PVP · Wound Care/Tissue Regeneration
Collagen-PVP is a composite biomaterial that combines collagen with polyvinylpyrrolidone to provide structural support and promote tissue regeneration and wound healing.
Phase 2 pipeline
- Hydroxychloroquine with Azithromycin · Infectious Disease
Hydroxychloroquine is a chloroquine derivative that inhibits heme polymerase, while Azithromycin is a macrolide antibiotic that inhibits protein synthesis.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Coordinación de Investigación en Salud, Mexico portfolio CI brief
- Coordinación de Investigación en Salud, Mexico pipeline updates RSS
Frequently asked questions about Coordinación de Investigación en Salud, Mexico
What are Coordinación de Investigación en Salud, Mexico's marketed drugs?
Top marketed products include starch tablets, Telmisartan plus Captopril, Triticum Aestivum.
What is Coordinación de Investigación en Salud, Mexico's pipeline?
Coordinación de Investigación en Salud, Mexico has 1 drugs in Phase 3, 1 in Phase 2, 4 in Phase 1. Late-stage candidates include Collagen-PVP.
Related
- starch tablets · Nutritional supplement / Pharmaceutical excipient
- Telmisartan plus Captopril
- Triticum Aestivum · Nutritional Support / Immunomodulation
- Sector hub: All tracked pharma companies